FIGURE 1.
Experimental design and timeline. (A) Mice were subjected to a 9-min cardiac arrest surgery followed by cardiopulmonary resuscitation (CA/CPR) or a sham operation. Vehicle or AA147 (ATF6 activator; 2 mg/kg) was administered intraperitoneally 1 day before surgery and intravenously 15 min after the return of spontaneous circulation (ROSC) once again. The impact of AA147 on CA/CPR-induced oxidative stress and ER stress-related apoptosis as well as activation of the ATF6 and Nrf2 signaling pathways was detected at 1 day after CA/CPR. The effect of AA147 on neuroprotection after CA/CPR was evaluated at 3 days after CA/CPR. Groups: (1) Sham + Vehicle; (2) CA/CPR + Vehicle; (3) CA/CPR + AA147. (B) Ceapin-A7 (ATF6 inhibitor; 10 mg/kg) or ML385 (Nrf2 inhibitor; 30 mg/kg) was administered intraperitoneally 2 h before administration of AA147. The role of AA147-induced activation of the ATF6 or Nrf2 in the neuroprotective effect of AA147 against post-CA/CPR cerebral ischemia/reperfusion injury was assessed at respective timepoint. Groups: (1) CA/CPR + AA147 + Vehicle; (2) CA/CPR + AA147 + Ceapin-A7; (3) CA/CPR + AA147 + ML385.
